FBRX

Forte Biosciences (FBRX)

Forte Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FBRX

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FBRX	Forte Biosciences Inc
2024/05/14	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2024/02/17	06 : 16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
2024/02/15	06 : 54	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FBRX	Forte Biosciences Inc
2024/01/06	07 : 27	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
2024/01/04	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2024/01/04	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/21	00 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/16	08 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/13	09 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/09	09 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/09	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2023/11/23	07 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/11/14	06 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FBRX	Forte Biosciences Inc
2023/10/04	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/10/04	05 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/27	05 : 16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/15	05 : 00	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/14	23 : 50	Business Wire	ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/11	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/09	05 : 36	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/07	05 : 31	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/07	04 : 15	Business Wire	Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom	NASDAQ:FBRX	Forte Biosciences Inc